Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19

In an international meeting, regulators have agreed to progress alignment on pre- and post-authorisation regulatory requirements to facilitate the rapid development, evaluation and availability of medicines for the treatment and prevention of coronavirus disease.


European Medicines Agency